Europe Human Growth Hormone Market

The European market for human growth hormone (hGH) involves protein hormone therapies that stimulate growth, cell reproduction, and regeneration. The primary customers are pediatric and adult patients with conditions such as Growth Hormone Deficiency, Turner Syndrome, and Prader-Willi Syndrome. Key growth drivers include a supportive regulatory framework from the European Medicines Agency, the increasing adoption of more affordable biosimilar hGH products, and the development of long-acting formulations that improve patient adherence.